EUR/USD Weekly Preview: CPI, PPI, ECB
In two weeks, the forex market will de facto go on a Christmas/New 12 months trip, which is not going ...
Tag: Preview
Dow Jones, Nasdaq, S&P 500 weekly preview: Attention turns to Nvidia earnings By Investing.com
Investing.com -- Shares dropped sharply on Friday because the post-election rally misplaced steam and issues over the trajectory of rates ...
Earnings Preview: Deere & Company expected to end FY24 on a mixed note | AlphaStreet
For Deere & Firm (NYSE: DE), 2024 has been a difficult 12 months marked by weak demand amid declining farm ...
Dow Jones, Nasdaq, S&P 500 weekly preview: Markets await CPI, retail sales data By Investing.com
Investing.com -- The inventory market set recent information on Friday, with the Dow Jones and concluding their strongest week in ...
Earnings Preview: What to look for when Shopify reports Q3 results | AlphaStreet
Shopify Inc. (NYSE: SHOP) delivered a powerful monetary efficiency within the first half of fiscal 2024, navigating a blended client ...
Earnings Preview: How the new fiscal year is shaping up for Cisco (CSCO) | AlphaStreet
For Cisco Programs Inc. (NASDAQ: CSCO), fiscal 2024 was a momentous yr with sturdy order development and an upswing in ...
Earnings Preview: Home Depot’s Q3 report likely to reflect weak consumer demand | AlphaStreet
The US housing trade has been largely resilient to headwinds like financial uncertainties thus far this yr. Nonetheless, housing exercise ...
MPC preview: Rate cut pace to slow – Mortgage Strategy
Markets anticipate the Financial institution of England to chop the bottom charge when it meets on Thursday – however the ...
HCLTech Q2 Results Preview: Dollar revenue likely to grow 1% sequentially to $3,395 million, margin may expand by 50 bps
HCLTech Q2 FY25 Outcomes Preview: Noida-headquartered HCLTech is ready to report its monetary outcomes for the July-September interval on Monday, ...
Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode | AlphaStreet
Through the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant participant within the medical {industry}, benefitting from its ...